Literature DB >> 30013649

Identification of differentially expressed genes in cervical cancer by bioinformatics analysis.

Yanshan Ge1,2,3,4, Chaoyang Zhang1,2,3,4, Songshu Xiao5, Lin Liang1,2,3,4, Shan Liao6, Yanqi Xiang7, Ke Cao8, Hongxiang Chen9, Yanhong Zhou1,2,3,4.   

Abstract

Cervical cancer is the most common gynecological malignancy. In recent years, the incidence of cervical cancer has had a younger trend. Cervical cancer morbidity and mortality rates have been significantly reduced due to recent decades of cervical cytology screening leading to the early detection and treatment of cervical cancer and precancerous lesions. There are a number of methods used to treat cervical cancer and improve the survival rate. However, the prevalence and recurrence rates of cervical cancer are increasing every year. There is an urgent requirement for a better understanding of the molecular mechanism cervical cancer development. The present study used scientific information retrieval from the Gene Expression Omnibus database to download the GSE26511 dataset, which contained 39 samples, including 19 cervical cancer lymph node-positive samples and 20 cervical cancer lymph node-negative samples. Using Gene Ontology analysis, Kyoto Encyclopedia of Genes and Genomes analysis, and weighted gene co-expression network analysis, 1,263 differentially expressed genes were found that affected the biological processes, including 'cell cycle process', 'signaling pathways', 'immune response', 'cell activation', 'regulation of immune system process' and 'inflammatory response'. These areas should be the focus of study for cervical cancer in the future.

Entities:  

Keywords:  bioinformatics analysis; cervical cancer; differentially expressed gene

Year:  2018        PMID: 30013649      PMCID: PMC6036588          DOI: 10.3892/ol.2018.8953

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  48 in total

1.  Myc cooperates with β-catenin to drive gene expression in nephron progenitor cells.

Authors:  Xinchao Pan; Courtney M Karner; Thomas J Carroll
Journal:  Development       Date:  2017-10-09       Impact factor: 6.868

2.  Involvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer.

Authors:  Maartje G Noordhuis; Rudolf S N Fehrmann; G Bea A Wisman; Esther R Nijhuis; Jelmer J van Zanden; Perry D Moerland; Emiel Ver Loren van Themaat; Haukeline H Volders; Mirjam Kok; Klaske A ten Hoor; Harry Hollema; Elisabeth G E de Vries; Geertruida H de Bock; Ate G J van der Zee; Ed Schuuring
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

3.  P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.

Authors:  Zhe-ping Fang; Bei-ge Jiang; Xue-feng Gu; Bin Zhao; Rui-liang Ge; Fa-biao Zhang
Journal:  Acta Pharmacol Sin       Date:  2013-05-20       Impact factor: 6.150

Review 4.  Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review.

Authors:  Enrica Bentivegna; Sebastien Gouy; Amandine Maulard; Cyrus Chargari; Alexandra Leary; Philippe Morice
Journal:  Lancet Oncol       Date:  2016-06       Impact factor: 41.316

5.  Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes.

Authors:  Margaret H Einstein; Kay J Park; Yukio Sonoda; Jeanne Carter; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2008-10-29       Impact factor: 5.482

6.  Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.

Authors:  Jun Zhang; Tingting Yao; Zhongqiu Lin; Yali Gao
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

7.  Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Authors:  Paul J Collins; Michelle L McCully; Laura Martínez-Muñoz; César Santiago; James Wheeldon; Stephan Caucheteux; Sylvia Thelen; Valentina Cecchinato; Julia M Laufer; Vladimir Purvanov; Yoan R Monneau; Hugues Lortat-Jacob; Daniel F Legler; Mariagrazia Uguccioni; Marcus Thelen; Vincent Piguet; Mario Mellado; Bernhard Moser
Journal:  FASEB J       Date:  2017-03-30       Impact factor: 5.191

8.  MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.

Authors:  Ai-Hua Chen; Yu-E Qin; Wen-Fan Tang; Jing Tao; Hua-Mei Song; Manzhen Zuo
Journal:  Cancer Cell Int       Date:  2017-06-09       Impact factor: 5.722

9.  Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases.

Authors:  Rose Isono-Nakata; Hiroshi Tsubamoto; Tomoko Ueda; Kayo Inoue; Hiroaki Shibahara
Journal:  Gynecol Oncol Rep       Date:  2018-04-06

10.  Human papillomavirus and cervical cancer.

Authors:  Emma J Crosbie; Mark H Einstein; Silvia Franceschi; Henry C Kitchener
Journal:  Lancet       Date:  2013-04-23       Impact factor: 79.321

View more
  5 in total

1.  Construction of miRNA-mRNA networks for the identification of lung cancer biomarkers in liquid biopsies.

Authors:  Elena Espinosa Garcia; Macarena Arroyo Varela; Rafael Larrosa Jimenez; Josefa Gomez-Maldonado; Manuel Angel Cobo Dols; M Gonzalo Claros; Rocio Bautista Moreno
Journal:  Clin Transl Oncol       Date:  2022-10-13       Impact factor: 3.340

2.  The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.

Authors:  Yanhua Mou; Yao Zhang; Jinchun Wu; Busheng Hu; Chunfang Zhang; Chaojun Duan; Bin Li
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

3.  Nuclear factor IB is downregulated in vulvar squamous cell carcinoma (VSCC): Unravelling differentially expressed genes in VSCC through gene expression dataset analysis.

Authors:  Shatavisha Dasgupta; Patricia C Ewing-Graham; Thierry P P Van Den Bosch; Sigrid M A Swagemakers; Lindy A M Santegoets; Helena C Van Doorn; Peter J Van Der Spek; Senada Koljenović; Folkert J Van Kemenade
Journal:  Oncol Lett       Date:  2021-03-16       Impact factor: 2.967

Review 4.  Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges.

Authors:  Haiyan Zeng; Lei Li; Zhouhua Hou; Yapeng Zhang; Zhongxiang Tang; Shuiping Liu
Journal:  Int J Med Sci       Date:  2020-03-15       Impact factor: 3.738

5.  A transcriptional co-expression network-based approach to identify prognostic biomarkers in gastric carcinoma.

Authors:  Danqi Liu; Boting Zhou; Rangru Liu
Journal:  PeerJ       Date:  2020-02-14       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.